Testing for radioligand sensitivity to endogenous neurotransmitter release

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 3, 2009, Pages 472-

  Knudsen, Gitte M ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER; RADIOLIGAND; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CARBON; DIAGNOSTIC AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; ISOREMOXIPRIDE; PYRROLIDINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SALICYLAMIDE DERIVATIVE;

HUMAN; NEUROTRANSMITTER RELEASE; NONHUMAN; NOTE; POSITRON EMISSION TOMOGRAPHY; RADIOSENSITIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; BRAIN; METABOLISM; RADIOASSAY; SCINTISCANNING; SECRETION;

ANIMALS; BRAIN; CARBON RADIOISOTOPES; HUMANS; NEUROTRANSMITTER AGENTS; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RADIOLIGAND ASSAY; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SALICYLAMIDES;

EID: 60549116133     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1067-3     Document Type: Note

References (18)

1. M Laruelle Y Huang 2001 Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights Q J Nucl Med 45 2 124 138
2. M Laruelle A Abi-Dargham CH van Dyck R Gil CD D'Souza J Erdos 1996 Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects Proc Natl Acad Sci USA 93 17 9235 9240
3. A Breier TP Su R Saunders RE Carson BS Kolachana A de Bartolomeis 1997 Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method Proc Natl Acad Sci USA 94 6 2569 2574
4. A Carlsson N Waters ML Carlsson 1999 Neurotransmitter interactions in schizophrenia - therapeutic implications Biol Psychiatry 46 10 1388 1395
5. RE Carson MA Channing BK Vuong H Watabe P Herscovitch WC Eckelman 2000
6. DJ Doudet JE Holden 2003 Sequential versus nonsequential measurement of density and affinity of dopamine D2 receptors with [11C]raclopride: effect of methamphetamine J Cereb Blood Flow Metab 23 12 1489 1494
7. W Sun N Ginovart F Ko P Seeman S Kapur 2003 In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone Mol Pharmacol 63 2 456 462
8. Aalto S, Hirvonen J, Kaasinen V, Hagelberg N, Kajander J, Nagren K, et al. The effects of d-amphetamine on extrastriatal dopamine D(2)/D (3) receptors: a randomized, double-blind, placebo-controlled PET study with [(11)C]FLB 457 in healthy subjects. Eur J Nucl Med Mol Imaging 2008. doi: 10.1007/s00259-008- 0969-9.
9. LH Pinborg C Videbaek M Ziebell T Mackeprang L Friberg H Rasmussen 2007 [123I]Epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region Neuroimage 34 4 1450 1453
10. MC Asselin AJ Montgomery PM Grasby SP Hume 2007 Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region J Cereb Blood Flow Metab 27 2 378 392
11. AJ Montgomery MC Asselin L Farde PM Grasby 2007 Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET J Cereb Blood Flow Metab 27 2 369 377
12. S Aalto A Bruck M Laine K Nagren JO Rinne 2005 Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457 J Neurosci 25 10 2471 2477
13. A Abi-Dargham N Simpson L Kegeles R Parsey DR Hwang S Anjilvel 1999 PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756 Synapse 32 2 93 109
14. YH Chou P Karlsson C Halldin H Olsson L Farde 1999 A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain Psychopharmacology (Berl) 146 2 220 227
15. LH Pinborg KH Adams S Yndgaard SG Hasselbalch S Holm H Kristiansen 2004 [18F]Altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge J Cereb Blood Flow Metab 24 9 1037 1045
16. A Matusch R Hurlemann KE Rota OH Winz D Elmenhorst H Herzog 2007 Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans J Neural Transm 114 11 1433 1442
17. P Cumming DF Wong N Gillings J Hilton U Scheffel A Gjedde 2002 Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein J Cereb Blood Flow Metab 22 5 596 604
18. R Narendran DR Hwang M Slifstein PS Talbot D Erritzoe Y Huang 2004 In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride Synapse 52 3 188 208